GO:0140693 molecular condensate scaffold activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140693 molecular condensate scaffold activity describes the binding and bringing together of two or more macromolecules to permit their organization into a molecular condensate.
• Scaffold activity is a molecular function that nucleates phase separation, often through multivalent low-affinity interactions among proteins and nucleic acids.
• Key scaffold proteins include ZO-1/ZO-2 at tight junctions, Hippo pathway components, SynGAP, latrophilin-3, and teneurin-latrophilin complexes.
• Condensate scaffolds organize signaling hubs, synaptic junctions, vesicle transport, and translational control.
• Dysregulated condensate scaffold activity is linked to cancer, neurodegeneration, and synaptic disorders.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of scaffold function in condensates.
Description
Molecular condensate scaffold activity (GO:0140693) is a molecular function defined as binding and bringing together two or more macromolecules in contact, permitting those molecules to organize as a molecular condensate. This activity is central to the formation of membraneless organelles and signaling compartments that concentrate specific proteins and nucleic acids. Unlike classical enzymatic activities, scaffold activity is primarily structural and organizational, relying on multivalent interaction domains that mediate liquid-liquid phase separation. Researchers study this term because condensates formed through scaffold activity regulate diverse processes including vesicle transport, synaptic assembly, and translational activation. For example, short-distance vesicle transport can be driven by phase separation, where scaffold proteins bring vesicles and motor proteins into a condensate. Similarly, the tight junction scaffold ZO-1 undergoes phase separation to drive junction formation. Understanding GO:0140693 therefore provides a mechanistic framework for how cells spatially organize biochemical reactions without membranes.
molecular condensate scaffold activity At A Glance
| GO ID | GO:0140693 |
|---|---|
| GO term | molecular condensate scaffold activity |
| Ontology | molecular_function |
| Synonym | phase separation nucleation activity; phase separation nucleator activity |
| Major function | Binding and bringing together two or more macromolecules to permit their organization as a molecular condensate |
| Related processes | Liquid-liquid phase separation, membraneless organelle assembly, signaling hub formation |
| Example scaffolds | ZO-1, ZO-2, Hippo pathway components, SynGAP, latrophilin-3, teneurin |
| Disease relevance | Cancer, neurodegeneration, synaptic disorders |
What Is GO:0140693?
In our own words, GO:0140693 molecular condensate scaffold activity is the function of a molecule that binds two or more macromolecules and holds them in close proximity so that they can assemble into a molecular condensate. This activity is also known as phase separation nucleation activity or phase separation nucleator activity. It does not require catalysis; instead, it depends on multivalent binding interfaces that lower the energetic barrier for condensate formation.
Why Is molecular condensate scaffold activity Important in Cell Biology?
GO:0140693 is important because it explains how cells create membraneless compartments that concentrate specific molecules to drive signaling, transport, and assembly processes. Dysregulation of scaffold activity can lead to pathological condensates associated with cancer and neurodegeneration. Targeting scaffold interactions is therefore an emerging therapeutic strategy.
• Defines a core mechanism for membraneless organelle formation.
• Enables spatial control of biochemical reactions without membranes.
• Critical for tight junction assembly and epithelial barrier function.
• Regulates Hippo signaling and organ size control.
• Essential for synaptic junction formation and plasticity.
• Involved in short-distance vesicle transport.
• Linked to translational activation within ribonucleoprotein granules.
• Dysregulated in prostate cancer through SPOP mutations.
• Implicated in synaptic disorders and cognitive dysfunction.
• Provides a target for condensate-modulating therapeutics.
What Happens During molecular condensate scaffold activity?
Scaffold recognition and multivalent binding
In simple terms: Scaffold proteins grab multiple partners at once.
Scaffold proteins contain multiple interaction domains that bind two or more macromolecules simultaneously. For example, ZO-1 uses multivalent interactions to bring together tight junction proteins. This multivalency is a prerequisite for condensate nucleation.
Nucleation and phase separation
In simple terms: The scaffold lowers the barrier for droplets to form.
Once bound, the scaffold reduces the energetic threshold for liquid-liquid phase separation, allowing the complex to condense into a distinct phase. Hippo signaling complexes phase separate through scaffold activity to form signaling hubs.
Condensate maturation and function
In simple terms: The droplet grows and performs its job.
The nascent condensate recruits additional components and matures into a functional compartment. In vesicle transport, phase-separated condensates mediate short-distance movement of vesicles. In ribonucleoprotein granules, condensates directly activate translation.
Dynamic regulation and disassembly
In simple terms: Droplets can form and fall apart as needed.
Condensates are dynamic and can be regulated by post-translational modifications, binding partners, and environmental conditions. SynGAP condensates at synapses are regulated independently of its catalytic activity, highlighting scaffold-specific regulation.
Key Genes Involved in GO:0140693 molecular condensate scaffold activity
The following genes and proteins have been experimentally linked to molecular condensate scaffold activity (GO:0140693) in published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TJP1 (ZO-1) | Tight junction scaffold | Phase separation drives tight junction formation |
| TJP2 (ZO-2) | Tight junction scaffold | Cooperates with ZO-1 in junction assembly |
| SPOP | Cullin-based E3 ligase substrate adaptor | Mutations promote p62-dependent autophagy and Nrf2 activation |
| SQSTM1 (p62) | Autophagy receptor and scaffold | Mediates SPOP-mutant effects in prostate cancer |
| NFE2L2 (Nrf2) | Transcription factor | Activated downstream of SPOP mutations |
| LATS1/2 | Hippo pathway kinases | Phase separation of Hippo complexes |
| YAP1 | Hippo pathway effector | Regulated by Hippo condensates |
| SYNGAP1 | Synaptic scaffold | Regulates synaptic plasticity independently of catalysis |
| ADGRL3 (Latrophilin-3) | Adhesion GPCR | Alternative splicing controls synapse formation |
| TENM1-4 (Teneurin) | Synaptic adhesion molecule | Forms complexes with latrophilin to reconstitute synaptic junctions |
| LPHN1-3 (Latrophilin) | Adhesion GPCR family | Scaffolds synaptic junction assembly |
| PABPC1 | Poly(A)-binding protein | Component of ribonucleoprotein granules |
| EIF4E | Translation initiation factor | Recruited to granules for translational activation |
| EIF4G | Translation initiation factor | Scaffolded in ribonucleoprotein granules |
| G3BP1 | Stress granule scaffold | Model scaffold for condensate studies |
| FUS | RNA-binding protein | Forms condensates linked to neurodegeneration |
| TARDBP (TDP-43) | RNA-binding protein | Pathological condensates in ALS |
How Is molecular condensate scaffold activity Regulated?
Scaffold activity is regulated by post-translational modifications, alternative splicing, and interaction with regulatory partners. For example, alternative splicing of latrophilin-3 controls its ability to scaffold synapse formation. SPOP mutations alter scaffold-dependent autophagy and Nrf2 activation. SynGAP condensates are regulated independently of its catalytic activity, indicating that scaffold function is a distinct regulatory layer.
molecular condensate scaffold activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SPOP | Prostate cancer | Knock-in of patient mutations in prostate cell lines |
| SQSTM1 | Autophagy dysregulation | Knockout in cancer cell lines |
| SYNGAP1 | Intellectual disability | Knockout and point-mutation in neurons |
| ADGRL3 | Neurodevelopmental disorders | Splice-variant knock-in in neurons |
| FUS | ALS | Overexpression of mutant FUS in neurons |
Cancer
SPOP mutations promote p62/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer, linking scaffold dysregulation to tumorigenesis. Condensate scaffolds can concentrate oncogenic signaling components, and their disruption is a potential therapeutic strategy.
Neurodegeneration
Pathological condensates of RNA-binding proteins such as FUS and TDP-43 are hallmarks of ALS and frontotemporal dementia. Scaffold activity that normally maintains dynamic condensates can become aberrant, leading to solid-like aggregates.
Synaptic and cognitive disorders
SynGAP condensates regulate synaptic plasticity and cognition independently of its catalytic activity, and mutations are linked to intellectual disability. Latrophilin-3 splicing controls synapse formation, with implications for neurodevelopmental disorders.
From molecular condensate scaffold activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does the gene scaffold condensate formation? | Knockout cell line followed by live-cell imaging |
| Which domains mediate multivalent binding? | Point mutations in interaction domains |
| Does a disease mutation alter phase separation? | Knock-in of patient mutation |
| Where does the scaffold localize in cells? | Tagged knock-in with fluorescent protein |
| Does overexpression drive pathological condensation? | Inducible overexpression |
| Can condensate formation be reconstituted in vitro? | Recombinant protein phase separation assay |
How to Study the molecular condensate scaffold activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell fluorescence imaging | Condensate formation and dynamics | Visualizing scaffold-driven phase separation |
| FRAP | Molecular exchange rates | Assessing liquid-like properties |
| In vitro phase separation assay | Reconstitution of condensates | Testing minimal scaffold components |
| Co-immunoprecipitation | Protein-protein interactions | Identifying scaffold partners |
| Mass spectrometry | Condensate proteome | Discovering recruited components |
| CRISPR knockout | Loss-of-function phenotype | Testing necessity of scaffold |
| CRISPR knock-in | Tagged or mutant protein expression | Localizing and mutating scaffold domains |
| Ribo-seq | Translation efficiency | Measuring translational activation by granules |
Live-cell imaging of condensates
Fluorescence microscopy of tagged scaffold proteins allows real-time visualization of condensate formation, fusion, and disassembly. FRAP and single-particle tracking quantify dynamics.
In vitro reconstitution
Recombinant scaffold proteins and binding partners can be mixed to reconstitute phase separation, as shown for teneurin-latrophilin synaptic junctions and ribonucleoprotein granules.
Proteomics of condensates
Biochemical fractionation and mass spectrometry identify components recruited to condensates, revealing scaffold interaction networks.
CRISPR-based functional dissection
Knockout, point-mutation, and knock-in models test the causal role of specific domains and residues in scaffold activity.
How CRISPR Can Be Used to Study GO:0140693 molecular condensate scaffold activity
Knockout
CRISPR knockout of scaffold genes such as TJP1 or SYNGAP1 abolishes condensate formation and reveals downstream phenotypes. Knockout cell lines are essential for testing necessity.
Point Mutation
Point mutations in multivalent interaction domains can selectively disrupt scaffold activity without affecting other functions, as shown for SynGAP and ZO-1.
Knock-in
Knock-in of fluorescent tags or disease-associated mutations allows tracking of scaffold localization and phase behavior in physiological context.
Overexpression
Overexpression of scaffold proteins can drive excessive condensate formation, modeling pathological states seen in cancer and neurodegeneration.
How EDITGENE Supports molecular condensate scaffold activity Research
Researchers studying molecular condensate scaffold activity-related genes often need to determine whether a candidate gene is causally involved in condensate formation, and which domains or residues are required. EDITGENE provides CRISPR-based cell models and screening services to dissect scaffold function with precision.
Contact EDITGENE today to design your custom CRISPR model for molecular condensate scaffold activity research.
Frequently Asked Questions About molecular condensate scaffold activity
What is molecular condensate scaffold activity?
It is a molecular function (GO:0140693) where a molecule binds two or more macromolecules and brings them together to permit their organization into a molecular condensate.
What genes are involved in molecular condensate scaffold activity?
Key genes include TJP1 (ZO-1), TJP2 (ZO-2), SPOP, SQSTM1, SYNGAP1, ADGRL3, and Hippo pathway components.
How does phase separation relate to GO:0140693?
Phase separation is the physical process that scaffold activity nucleates; the scaffold lowers the barrier for condensate formation.
What diseases are linked to condensate scaffold dysfunction?
Cancer, neurodegeneration, and synaptic disorders have been linked to dysregulated scaffold activity.
What methods study molecular condensate scaffold activity?
Live-cell imaging, FRAP, in vitro reconstitution, proteomics, and CRISPR screens are commonly used.
Can CRISPR knockout help study scaffold function?
Yes, knockout of scaffold genes abolishes condensate formation and reveals downstream phenotypes.
What is the difference between scaffold and client proteins in condensates?
Scaffolds nucleate condensates through multivalent binding, while clients are recruited but do not drive formation.
How is scaffold activity regulated?
It is regulated by post-translational modifications, alternative splicing, and interaction partners.
What is an example of a scaffold-driven condensate?
ZO-1 phase separation drives tight junction formation, and SynGAP condensates regulate synaptic plasticity.
How can I model scaffold mutations with CRISPR?
Point-mutation knock-in models introduce specific mutations to test domain requirements.
Conclusion
GO:0140693 molecular condensate scaffold activity is a fundamental molecular function that organizes macromolecules into condensates, impacting signaling, transport, and synaptic assembly. Its dysregulation contributes to cancer and neurodegeneration, making it a compelling therapeutic target. CRISPR-based models are powerful tools to dissect scaffold mechanisms and identify intervention points.
References
- 1. Qiu H et al.. 2024. Short-distance vesicle transport via phase separation.. Cell 187(9):2175-2193.e21 PMID: 38552623
- 2. Beutel O et al.. 2019. Phase Separation of Zonula Occludens Proteins Drives Formation of Tight Junctions.. Cell 179(4):923-936.e11 PMID: 31675499
- 3. Zhang X et al.. 2025. Reconstitution of synaptic junctions orchestrated by teneurin-latrophilin complexes.. Science 387(6731):322-329 PMID: 39818903
- 4. Shi Q et al.. 2022. SPOP mutations promote p62/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer.. Cell Death Differ 29(6):1228-1239 PMID: 34987184
- 5. Bonello TT et al.. 2023. Phase separation of Hippo signalling complexes.. EMBO J 42(6):e112863 PMID: 36807601
- 6. Araki Y et al.. 2024. SynGAP regulates synaptic plasticity and cognition independently of its catalytic activity.. Science 383(6686):eadk1291 PMID: 38422154
- 7. Wang S et al.. 2024. Alternative splicing of latrophilin-3 controls synapse formation.. Nature 626(7997):128-135 PMID: 38233523
- 8. Chen R et al.. 2024. Direct observation of translational activation by a ribonucleoprotein granule.. Nat Cell Biol 26(8):1322-1335 PMID: 38965420
